GT BIOPHARMA INC

CUSIP: 36254L209 Class: COMMON

CHARLES SCHWAB INVESTMENT MANAGEMENT INC's Holding History (CIK: 0000884546)

Note: Option positions (PUT/CALL) are excluded.

Q2 2022
Shares 25,869 Value ($000) $78 Avg Close — Range —
Q1 2022
Shares 38,229 Value ($000) $111 Avg Close — Range —
Q4 2021
Shares 45,664 Value ($000) $140 Avg Close — Range —
Q3 2021
Shares 45,664 Value ($000) $308 Avg Close — Range —
Q2 2021
Shares 57,993 Value ($000) $899 Avg Close — Range —